Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

Abstract Background Ovarian carcinoma is the most lethal gynecological malignancy due to early dissemination and acquired resistance to platinum-based chemotherapy. Reliable markers that are independent and complementary to clinical parameters are needed to improve the management of patients with th...

Full description

Bibliographic Details
Main Authors: Cécile Le Page, Kurosh Rahimi, Martin Köbel, Patricia N. Tonin, Liliane Meunier, Lise Portelance, Monique Bernard, Brad H. Nelson, Marcus Q. Bernardini, John M. S. Bartlett, Dimcho Bachvarov, Walter H. Gotlieb, Blake Gilks, Jessica N. McAlpine, Mark W. Nachtigal, Alain Piché, Peter H. Watson, Barbara Vanderhyden, David G. Huntsman, Diane M. Provencher, Anne-Marie Mes-Masson
Format: Article
Language:English
Published: BMC 2018-03-01
Series:BMC Cancer
Subjects:
Epithelial ovarian cancer
Histotype
Biomarker
BRCA
Survival
Treatment response
Online Access:http://link.springer.com/article/10.1186/s12885-018-4242-8

Internet

http://link.springer.com/article/10.1186/s12885-018-4242-8

Similar Items